Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
American Journal of Hypertension|June 5, 2004
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertensionKenneth A Jamerson, Oliseyenum Nwose, Lisa Jean-Louis, et al.Current Medical Research and Opinion|September 13, 2011
Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patientsRobert M Guthrie, Björn Dahlöf, Kenneth A Jamerson, et al.Hypertension (Dallas, Tex. : 1979)|August 24, 2005
A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensivesMatthew R Weir, Keith C Ferdinand, John M Flack, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|December 23, 2003
Meeting the challenge to improve the treatment of hypertension in blacksAntonio Alberto Lopes, Sherman A James, Friedrich K Port, et al.Contemporary Clinical Trials|July 22, 2008
Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertensionCrystal A Gadegbeku, Phyllis Kreger Stillman, Mark D Huffman, et al.American Journal of Hypertension|November 20, 2020
Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant HypertensionRobert D Brook, Niko Kaciroti, George Bakris, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 18, 2008
Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal diseaseScott S Billecke, Louis G D'Alecy, Raylene Platel, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2007
Periodontal disease and other nontraditional risk factors for CKDMonica A Fisher, George W Taylor, Brent J Shelton, et al.American Journal of Hypertension|September 15, 2004
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertensionKenneth A Jamerson, George L Bakris, Chuan-Chuan Wun, et al.Hypertension (Dallas, Tex. : 1979)|November 17, 2021
Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment GuidelinesBrent M Egan, Jianing Yang, Michael K Rakotz, et al.Pageof 4